SCHEMBL4967707

SCHEMBL4967707

C1=C[C@@H]2CCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22129636 1.00
SCHEMBL36991 1.00
SCHEMBL6065835 1.00
SCHEMBL11183068 1.00
Calcium SCHEMBL31207302 0.96
SCHEMBL31273742 0.96
SCHEMBL539985 0.96
SCHEMBL31207299 0.96
SCHEMBL31207303 0.96
Charcoal, Activated SCHEMBL9015473 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966381-A2 METHOD FOR THE ENZYMATIC PRODUCTION OF 5-NORBORNEN-2-CARBOXYLIC ACID BASF SE (DE) 2008-09-10 EP claimed
WO-2007071578-A2 METHOD FOR PRODUCING 5-NORBORNEN-2-CARBOXYLIC ACID FROM 5-NORBORNEN-2-CARBONITRILE USING AN ARYLACETONITRILASE BASF SE (DE) 2007-06-28 WO claimed
US-20250041488-A1 HYDROGEL MICROPARTICLE-BASED SOFT TISSUE FILLERS Likarda, Inc. 2025-02-06 US disclosed
US-20230250248-A1 CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING ILLUMINA, INC. 2023-08-10 US disclosed
US-11618808-B2 Catalyst-free surface functionalization and polymer grafting ILLUMINA, INC. (US) 2023-04-04 US disclosed
EP-3919624-A2 CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING Illumina, Inc. (US) 2021-12-08 EP disclosed
US-20210189082-A1 CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING ILLUMINA, INC. 2021-06-24 US disclosed
US-10975210-B2 Catalyst-free surface functionalization and polymer grafting ILLUMINA, INC. (US) 2021-04-13 US disclosed
EP-3431614-A1 CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING Illumina, Inc. (US) 2019-01-23 EP disclosed
US-20180265660-A1 CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING ILLUMINA, INC. 2018-09-20 US disclosed
EP-3017065-B1 CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING ILLUMINA INC (US) 2018-09-12 EP disclosed
EP-1607414-A1 A catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY (US) 2005-12-21 EP disclosed
EP-1607413-A1 A catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY (US) 2005-12-21 EP disclosed
US-20050277569-A1 Catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY 2005-12-15 US disclosed
US-20050277749-A1 Catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY 2005-12-15 US disclosed
CN-1590457-A Curable composition and its use MITSUI CHEMICALS INC (JP) 2005-03-09 CN disclosed
US-20050043494-A1 Catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY 2005-02-24 US disclosed
EP-1508577-A1 A catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY (US) 2005-02-23 EP disclosed
CN-1050835-C 1, 5-benzodiazepine * derivatives, their preparation and their pharmaceutical use GLAXO SPA (IT) 2000-03-29 CN disclosed
CN-1138853-A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists GLAXO SPA (IT) 1996-12-25 CN disclosed